Skip to main content

Renal mitochondria response to sepsis: a sequential biopsy evaluation of experimental porcine model.

Intensive care medicine experimental2025-02-22PubMed
Total: 80.0Innovation: 8Impact: 8Rigor: 8Citation: 8

Summary

In a randomized porcine fecal peritonitis model with sequential renal biopsies, high-severity sepsis caused an early decrease in oxidative phosphorylation and increased uncoupling that preceded macro-hemodynamic changes and coincided with rises in serum creatinine. Renal medulla exhibited lower mitochondrial capacity than cortex, and PGC-1α was reduced in high-severity animals. These data suggest severity-dependent mitochondrial endotypes in sepsis-induced AKI.

Key Findings

  • High-severity sepsis caused decreased oxidative phosphorylation and increased uncoupling within 24 hours, preceding renal macro-hemodynamic changes.
  • Serum creatinine rose early, indicating renal dysfunction not primarily driven by hemodynamics.
  • Renal medulla had lower oxidative phosphorylation and ETS activity than cortex; PGC-1α decreased in high-severity animals.

Clinical Implications

Renal dysfunction in severe sepsis may be driven by early mitochondrial failure rather than macro-hemodynamics, supporting early mitochondrial-targeted diagnostics and therapies (e.g., biogenesis enhancers) and suggesting phenotype-specific trial designs for SA-AKI.

Why It Matters

This large-animal, sequential tissue study reconciles conflicting preclinical findings by showing early, severity-dependent mitochondrial dysfunction that is independent of macro-hemodynamics, reframing SA-AKI mechanisms.

Limitations

  • Small sample size (n=15) and open-label design in a single preclinical model
  • Short observation window (~24 h) limits assessment of longer-term renal recovery or fibrosis

Future Directions

Define SA-AKI mitochondrial endotypes prospectively in humans, test mitochondrial biogenesis/uncoupling modulators, and integrate renal regional oxygenation imaging with bioenergetic biomarkers.

Study Information

Study Type
RCT
Research Domain
Pathophysiology
Evidence Level
IV - Randomized preclinical (animal) experiment; not a human clinical trial.
Study Design
OTHER